Research and Development
Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial
December 14, 2022 Research and Development
Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …
ClearPoint recruits first patient in laser therapy study to treat Glioblastoma
December 14, 2022 Research and Development
California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …
AI model predicts CVD risk from single chest radiograph
December 14, 2022 Research and Development
A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …
Autolus announces positive primary endpoint data in FELIX trial
December 13, 2022 Research and Development
Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …
Seagen shares data for Adcetris combination for Hodgkin Lymphoma
December 13, 2022 Research and Development
Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …
New blood cancer treatment appears successful for most trial patients
December 12, 2022 Research and Development
A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …
Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials
December 6, 2022 Research and Development
BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease …
Nkarta data supports natural killer cells in cancer treatment
December 6, 2022 Research and Development
San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is …
Innovent Biologics and UNION Therapeutics announce first dosing of Chinese subject in phase 1 study
December 5, 2022 Research and Development
Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the scope of …
Amgen’s obesity drug appears promising with few side effects
December 5, 2022 Research and Development
Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to …
New insights into HIV vaccine revealed by researchers
December 5, 2022 Research and Development
Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for …
GSK’s two new cancer drugs look promising
December 2, 2022 Research and Development
GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial …
Elon Musk’s Neuralink to conduct human trials in 2023
December 1, 2022 Research and Development
Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to …
Stem cell transplants could be offered to MS patients in new trial
November 30, 2022 Research and Development
In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …
Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates
November 30, 2022 Research and Development
Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
